Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript February 21, 2024 Repligen Corporation reports earnings inline with expectations. Reported EPS is $0.33 EPS, expectations were $0.33. Repligen Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, ladies and […]
Repligen posts Q4 2023 results. CEO Tony Hunt highlights order strength in Filtration and Analytics. Positive momentum in new modalities; 2024 revenue forecast: $620-$650 million.
Repligen Corporation RGEN reported fourth-quarter 2023 adjusted EPS of $0.33, in line with the consensus estimate. The life science company reported sales of…